Lennox-Gastaut Syndrome clinical trials at UC Irvine

1 research study open to eligible people

Clemizole HCl in Patients With Lennox-Gastaut Syndrome
open to eligible people ages 2-55
This is a multicenter, Phase 3, randomized, double-blind, placebo-controlled study designed to evaluate the efficacy and safety of clemizole HCL (EPX-100) as adjunctive therapy in children and adult participants with Lennox-Gastaut syndrome (LGS).
Orange, California and other locations

Last updated: April 13, 2026